Operational Update: Aurora Cannabis Surpasses 4,500 Registered Patients

Licensed Producer Launching Same-Day Delivery in Edmonton

CSE: ACB

VANCOUVER, July 4, 2016 /CNW/ - Aurora Cannabis Inc. (CSE: ACB) (FRANKFURT: 21P) (WKN: A1C4WM) (OTCQB: ACBFF) ("Aurora" or the "Company") is pleased to provide the following operational update.

Patient Registration Increasing Rapidly

On June 30, 2016, Aurora surpassed 4,500 active registered patients, less than six months after the Company's first sale of product. This is believed to be the fastest rate of patient registration after commencement of commercial operations achieved by any Licensed Producer in Canada. In addition, Aurora's customer retention rate remains well in excess of 90 per cent.

Product Sales Increase 45% in One Month

Sales of dried cannabis increased across the full product line, with total weight of product sold in June 2016 reaching 100,000 grams, versus 69,000 grams sold in May, 2016.

Launch of Same-Day Delivery in Edmonton

Effective July 5, 2016, medical cannabis patients in the Edmonton area who are registered with Aurora can now order products Monday to Friday by 10:00 am Mountain Time (MT), and have their order delivered by or before 8:00 pm MT the same day. This service, which comes at no additional cost, will be offered to customers in Edmonton and surrounding municipalities, including Nisku, Sherwood Park, St. Albert, Spruce Grove and Fort Saskatchewan.

Aurora, which was the first Licensed Producer to launch same-day delivery of medical cannabis, is now the first company to offer this service in two cities. As announced on May 24, 2016, the Company began same-day product delivery in Calgary and surrounding communities. Extension of same-day order delivery to Red Deer is anticipated within the next few weeks.

Production Approaching Full Capacity

All 10 flower (growing) rooms at Aurora's advanced and heavily automated production facility are now in use, with sequenced harvests scheduled for the largest number of cultivars the Company has had in simultaneous production. The facility is expected to be producing at full capacity by the end of July, 2016.

"We are absolutely delighted by how smoothly our production is scaling up to full capacity, and by the consistent increase in demand for Aurora's medical cannabis," said Terry Booth, CEO. "Yields are excellent, product quality is outstanding, and our customer care team is maintaining a remarkably high level of client satisfaction. Across all functions, we are meeting the Aurora Standard, setting the pace in our industry, and executing successfully on our business strategy."

About Aurora

Aurora's wholly-owned subsidiary, Aurora Cannabis Enterprises Inc., is a licensed producer of medical marijuana pursuant to the Marihuana for Medical Purposes Regulations and operates a 55,200 square foot, expandable, state-of-the-art production facility in Mountain View County, Alberta, Canada. Aurora trades on the Canadian Securities Exchange under the symbol "ACB".

On behalf of the Board of Directors, AURORA CANNABIS INC.

Terry Booth, CEO

This news release contains statements about the Company's expectations regarding production capacity, production yields and other aspects of its anticipated future operations that are forward-looking in nature and, as a result, are subject to certain risks and uncertainties. Although the Company believes that the expectations reflected in these forward-looking statements are reasonable, undue reliance should not be placed on them as actual results may differ materially from the forward-looking statements. Such forward-looking statements are estimates reflecting the Company's best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements. Such factors include but are not limited to the Company's ability to obtain the necessary financing and the general impact of financial market conditions, the yield from marijuana growing operations, product demand, changes in prices of required commodities, competition, government regulations and other risks set out in the Company's management's discussion and analysis filed on SEDAR. The forward-looking statements contained in this news release are made as of the date hereof, and the Company undertakes no obligation to update publicly or revise any forward-looking statements or information, except as required by law.

We seek Safe Harbour.

SOURCE Aurora Cannabis Inc.

Cam Battley, Senior VP Communications and Medical Affairs, +1.905.864.5525, [email protected], www.auroramj.com